Melbourne – September 04, 2026 -- SIBIONICS showcased its GS3 continuous glucose monitoring (CGM) sensor, integrating artificial intelligence for meal logging, food analysis and glucose trend insights, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21.

Melbourne – September 03, 2026 -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress in Melbourne, held August 18-21 and featuring a company booth, a scientific symposium and on-site interviews with certified diabetes educators (CDEs).

Melbourne – September 03, 2026 -- SIBIONICS showcased its AI-driven continuous glucose monitoring (CGM) sensor, GS3, at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress held in Melbourne from August 18 to 21, using a dedicated booth, a scientific symposium and on-site interviews with credentialed diabetes educators (CDEs).

Melbourne, Australia -- September 01, 2026 -- SIBIONICS presented its GS3 continuous glucose monitor at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from August 18 to 21, 2026. The company used Booth #1, a scientific symposium and on-site interviews with credentialled diabetes educators to demonstrate the sensor's AI-linked meal-logging and glucose-trend features. GS3 is a factory-calibrated, 14-day continuous glucose monitor with a 2.9 mm on-body profile.